Evaluating regional and global diffusion measures as biomarkers for VCID
Sheela Kumari Raghavan(WinnMed), Prashanthi Vemuri(Mayo Clinic in Arizona), Robert I. Reid(Mayo Clinic), Scott A. Przybelski(Mayo Clinic in Florida), Jonathan Graff-Radford(Mayo Clinic), Michael G. Kamykowski(Mayo Clinic), David S. Knopman(Mayo Clinic in Arizona), Val J. Lowe(Mayo Clinic), Ronald C. Petersen(University of California, Los Angeles), Clifford R. Jack(Mayo Clinic)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k